. Moreover, there was a high base in Q4’2017 since the market reacted to an announcement of the new excise tax imposed to RTD Tea before the regulation became effective in mid Sep’17. Although the challenging

by 22.3%. The number of both in-patient and out-paient were increased by 9.3%. Revenue from out-patient and in-patient were increased by 8.4% and 17.2%. Cost of medical treatments The Cost of medical

profit by increasing revenue from all products and sales channels, effective cost and expense management. As a result, the Company is able to make an operating profit since quarter 2 year 2019. The

by promoting expansive information access, new services by newcomers, cost-effective market infrastructure leading to lower operating costs. Additionally, the SEC will use RegTech for a better

cost from relocating some product from the old production line to the new one; 4) higher excise tax as well as sugar tax following the Excise Act, B.E. 2560, effective since 16 September 2017; 5) higher

. 2. Cost of Sales and Services, Selling and Servicing Expenses and Administrative Expenses The cost of sales and services, the selling and servicing expenses and the administrative expenses of the

Cloud Computing business of Baht 12.92 million; - Other revenue of Baht 1.94 million. 2. Cost of Sales and Services, Selling and Servicing Expenses and Administrative Expenses The cost of sales and

malls (i.e. common areas, convention halls, on-site-media, and promotional areas) by continuously rolling out a variety of marketing events in all projects. Continual effective cost management The lower

subsidiaries recorded cost of goods sold of Baht 977 million. Cost of goods sold to sales decreased to 80% from 83% in Q1/2019. Cost of goods sold ratio lessened 9%, mainly due to effective cost of goods sold

Assistant Professor Dr.Kusuma Palaprom the resigned Company’s Director effective since 30 October, 2017 2. Appointment of Assistant Dr. Chalermkiat Wongvanichtawee as the Independent Director to replace the